| This new issue contains the following articles: Review Article Exploring the diversity of CFTR gene mutations in cystic fibrosis individuals of South Asia Hassan Rafique, MPhil, Anum Safdar, MPhil, Muhammad Usman Ghani, PhD, Ali Akbar, FRCPCH, Farheena Iqbal Awan, PhD, Zartashay Naeem, MPhil, Ali Amar, PhD, Mudassar Fareed Awan, PhD, Syed Wajahat Ullah, MPhil & Rehan Sadiq Shaikh, PhD Pages: 511-519 | DOI: 10.1080/02770903.2023.2297365 Research Articles Exacerbations, treatment patterns, utilization, and costs before and after initiating of benralizumab for the treatment of severe eosinophilic asthma |  Joseph L. Smith, PhD, MPH, Yen Chung, PharmD, John Barron, PharmD, Theodore Barlows, PharmD, Bal Nepal, PhD, MPH & Donna Carstens, MD Pages: 520-531 | DOI: 10.1080/02770903.2023.2289169 Progressive clinical effects of the combination omalizumab and HDM – allergen immunotherapy in asthma Andrzej Bozek, MD, PhD, Barbara Rogala, MD, PhD, Martyna Miodonska, MD & Giorgio Walter Canonica, MD PhD Pages: 532-538 | DOI: 10.1080/02770903.2023.2293057 Characteristics of asthma in an older adult population according to sex and control level: why are asthma symptoms in older women not well-controlled? Dilek Karadoğan, MD, Elif Yılmazel Uçar, MD, Yasemin Yavuz, MD, Ayse Baccioglu, MD, Ayşe Bilge Öztürk, MD, Nurgül Bozkurt, MD, Murat Kavas, MD, Selen Karaoğlanoğlu, MD, TAAR Study Group, Gülfem Çelik, MD, Omur Aydin, Derya Gokmen, Gozde Koycu Buhari, Zeynep Celebi Sozener, Bilun Gemicioglu, Ismet Bulut, Sengul Beyaz, Cihan Orcen, Secil Kepil Ozdemir, Metin Keren, Ebru Damadoglu, Tugce Yakut, Ayse Fusun Kalpaklioglu, Sumeyra Alan Yalim, Insu Yilmaz, Ilkay Koca Kalkan, Mehmet Atilla Uysal, Elif Yelda Ozgun Niksarlioglu, Ali Fuat Kalyoncu, Gul Karakaya, Muge Erbay, Sibel Nayci, Fatma Merve Tepetam, Asli Akkor Gelincik, Hulya Dirol, Ozlem Goksel, Ferda Oner Erkekol, Sacide Rana Isik, Fusun Yildiz, Ummuhan Seker, Ipek Kivilcim Oguzulgen, Ilknur Basyigit, Serap Argun Baris, Elif Yilmazel Ucar, Tuba Erdogan, Mehmet Polatli, Dane Ediger, Fatma Esra Gunaydin, Murat Turk, Leyla Pur, Zeynep Yegin Katran, Yonca Sekibag, Enes Furkan Aykac, Dilsad Mungan, Ozcan Gul, Ali Cengiz, Bulent Akkurt, Seyma Ozden, Semra Demir, Derya Unal, Ayse Feyza Aslan, Ali Can, Reyhan Gumusburun, Gulhan Bogatekin, Hatice Serpil Akten, Sinem Inan, Munevver Erdinc, Aliye Candan Ogus, Demet Polat Yulug, Mehmet Erdem Cakmak, Saltuk Bugra Kaya, Gulistan Alpagat, Eylem Sercan Ozgur, Oguz Uzun, Sule Tas Gulen, Gulseren Pekbak, Deniz Kizilirmak, Havlucu Yavuz, Halil Donmez, Bahar Arslan, Gulden Pacaci Cetin, Sadan Soyyigit, Bilge Yilmaz Kara, Gulden Pasaoglu Karakis, Adile Berna Dursun, Resat Kendirlinan, Can Sevinc, Gokcen Omeroglu Simsek, Oznur Abadoglu, Pamir Cerci, Taskin Yucel, Irfan Yorulmaz, Zahide Ciler Tezcaner, Emel Cadalli Tatar, Ahmet Emre Suslu, Serdar Ozer, Engin Dursun & Arzu Yorgancioglu Pages: 539-549 | DOI: 10.1080/02770903.2023.2293062 The role of ACT score in mepolizumab discontinuation Neha Solanki, MD, Brittany Beck, MEd (Health), Monica Labadia, RN-BSN, Kevin Smith, BSc, Laura Peterson, BA, Stephanie King, MSN, RN, Sarah Micklewright, PA-C, Emily Pennington, MD, Sobia Farooq, MD, Peng Zhang, MD, Mark Aronica, MD, Joe Zein, MD, PhD, Sumita Khatri, MD, MS, Suzy Comhair, PhD & Serpil Erzurum, MD Pages: 550-560 | DOI: 10.1080/02770903.2023.2293067 The clinical effectiveness of mepolizumab treatment in severe eosinophilic asthma; outcomes from four years cohort evaluation Christopher Reilly, MBBcH, Anandavelu Raja, MBBcH, MRCP, Pillai Anilkumar, MD MRCP, Julie Sullivan, RN, Lisa White, RN, Ali Bahron, BSc, Julie Marsh, BTec & Adel H. Mansur, PhD FRCP Pages: 561-573 | DOI: 10.1080/02770903.2023.2294908 Doxofylline as a steroid-sparing treatment in Mexican children with asthma Sandra Nora González-Díaz, MD, PhD, Ignacio J. Ansotegui, MD, PhD, Carlos Macouzet-Sánchez, MD, PhD, Natalhie Acuña-Ortega, MD & Carlos de la Cruz-de la Cruz, MD Pages: 574-583 | DOI: 10.1080/02770903.2023.2294909 Impact of a discharge prescription for dexamethasone on outcomes of children treated in the emergency department for acute asthma exacerbations Melisa S. Tanverdi, MD, Nidhya Navanandan, MD, MSCS, Savannah Brackman, MD, Lorel Huber, MD, Jan Leonard, MSPH & Rakesh D. Mistry, MD, MS Pages: 584-593 | DOI: 10.1080/02770903.2023.2294910 Investigating the association between asthma and opioid use disorder with interactions of anxiety and depression among a national sample of the US population Fares Qeadan, PhD, MS, Ashlie McCunn, MPH, Benjamin Tingey, MSTAT, Ron Price, BA, Kathleen L. Bobay, PhD & Ali Imran Saeed, MD Pages: 594-607 | DOI: 10.1080/02770903.2023.2294911 Multivariate analysis and data mining help predict asthma exacerbations Stefan Mihaicuta, MD, PhD, Lucretia Udrescu, PharmD, PhD, Adrian Militaru, MSE, Valentin Nadasan, MD, PhD, Angelica Tiotiu, MD, PhD, Andras Bikov, MD, PhD, Sorin Ursoniu, MD, PhD, Romina Birza, MD, Alina Mirela Popa, MD & Stefan Frent, MD, PhD Pages: 608-618 | DOI: 10.1080/02770903.2023.2297366 Patient-reported outcome measures in severe asthma: an expert consensus | Eva Martínez-Moragón, MD, PhD, Ignacio Antepara Ercoreca, MD, PhD, María Muñoz García, PharmD PhD, on behalf of the PROs-SA group of experts, Francisco Casas Maldonado, MD PhD, Marta Calvín Lamas, PharmD PhD, Eusebi Chiner Vives, MD PhD, Carlos Crespo Diz, PharmD PhD, David Díaz-Pérez, NursingD, Ibon Eguiluz Gracia, MD PhD, Sara García Gil, PharmD, Ruperto González-Pérez, MD PhD, Alicia Habernau Mena, MD PhD, Tamara Hermida Valverde, MD, Sònia Jornet Montaña, PharmD, Valentín López-Carrasco, NursingD, Icíar Martínez López, PharmD PhD, Vicente Merino-Bohórquez, PharmD, Álvaro Moreno-Ancillo, MD, Ana Cristina Mínguez Cabeza, PharmD, Emilio Monte-Boquet, PharmD PhD, Jose Luis Revuelta-Herrero, PharmD & Silvia Sánchez-Cuellar, MD PhD Pages: 619-631 | DOI: 10.1080/02770903.2023.2297372 A qualitative study on asthma management experiences of Turkish community pharmacists Elif Ulutas Deniz, PhD, Ayşe Nazlı Gülakar & Rumeysa Eren Pages: 632-642 | DOI: 10.1080/02770903.2023.2297373 Case Reports Giant lung cavity due to three different pathogens in a patient receiving inhaled salmeterol plus fluticasone propionate for asthma Neşe Merve Güner Zırıh, MD, Bilge Yılmaz Kara, MD, Songül Özyurt, MD, Oğuzhan Okçu, MD, Tuğba İlgar, MD & Ünal Şahin, MD Pages: 643-648 | DOI: 10.1080/02770903.2023.2293069 A tailored approach to refractory severe Mepolizumab-associated headache: a case study Carmine Salerni, MD, Andrea Baccelli, MD, Elena M. Parazzini, MD, Rocco Rinaldo, MD & Stefano Centanni, MD, PhD Pages: 649-652 | DOI: 10.1080/02770903.2023.2294913 |